MeiraGTx Holdings plc MGTX
$9.73
▼ -0.10% 24H
About
MeiraGTx Holdings plc is a clinical-stage gene therapy company focused on developing novel treatments for serious diseases. The company's primary aim is to harness the transformative potential of gene therapy to address otherwise unmet medical needs. MeiraGTx's pipeline includes programs that target genetic disorders, …
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees409
TickerMGTX
Statistics
Market Cap$792.5M
Revenue (TTM)$81.4M
Net Income-$114.2M
Net Margin-140.3%
EPS$-1.48
P/E-6.76
P/S10.45
P/B-13.42
EV/EBITDA-9.37
ROE1971.4%
Dividend Yield—
Price$9.73
Data: Twelve Data · Revenue = mcap / P/S